Insurers Gain Early Wins in COVID-19 Business Interruption Lawsuits

Insurers have succeeded in dismissing COVID-19 business-interruption lawsuits in 17 out of 23 cases heard so far, with a growing number of judges finding that some tangible alteration of a property is required to trigger coverage under commercial property policies.

Read More

16 Drugmakers, Gates Foundation Promise COVID-19 Therapies, Vaccines Will Be Distributed Equally

A group of 16 drugmakers and the Bill and Melinda Gates Foundation signed a joint statement Sept. 30 promising that future COVID-19 therapies and vaccines will be distributed equally across the globe.

Read More

Uncertainty And Financial Stress Driving Closer Scrutiny Of Employee Benefits

At a time of economic upheaval and uncertainty, most businesses in the US are trying to maintain their current benefits offerings to employees, a new report from Aflac finds. At the same time, employees are taking a closer look at their policies and weighing what may work best for them in the future.

Read More

5 Things to Know About a COVID Vaccine: It Won’t Be a ‘Magic Wand’

President Donald Trump makes no secret he would like a COVID-19 vaccine to be available before the election. But it’s doubtful that will happen and, even after a vaccine wins FDA approval, there would be a long wait before it’s time to declare victory over the virus.

Read More

Supreme Court To Hear Arkansas PBM ERISA Appeal

Arkansas Solicitor General Nicholas Bronni will defend before the U.S. Supreme Court the constitutionality of a state law regulating pharmacy benefit managers next Tuesday.

Read More

Just Over Half Say They Would Get Low-Cost Vaccine If Available

Slightly more than half of respondents said they would get a low-cost coronavirus vaccine if it were available, according to a poll released on Monday.

Read More

Some Insurers Move To Stop Waiving Telehealth Copays

Starting Oct. 1, several private health insurers will no longer fully pay for virtual visits under certain circumstances — effectively reinstituting costs for patients reliant on the virtual care that has been heralded as a lifeline at a time when Covid-19 is still killing more than 700 Americans each day.

Read More

California To Make Its Own Insulin, Generic Drugs In Effort To Lower Costs

California could make its own insulin and other prescription drugs in an effort to lower costs under a bill Gov. Gavin Newsom announced he signed into law Monday.

Read More

Private Employers Show New Interest In Expanded Medicare And Regulated Drug Prices

U.S. employers, battered by rising hospital and pharmaceutical prices, are increasingly open to a bigger government role in healthcare, including regulating prices and expanding Medicare to more working Americans.

Read More

Vericred and CaliforniaChoice Key Players in Health Insurance Enrollment API Roll-Out

Beam, CaliforniaChoice, Kaiser Permanente and Oscar partner with Vericred to create a de facto standard for California group enrollment and member management

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square